Ronald Levy M.D. ’68, Stanford School of Medicine professor and associate director of the Stanford Cancer Institute (SCI), unveiled the research that led to the breakthrough cancer medication Rituxan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback